SD HEALTHCARERecent and archived news stories on: Biotechnology, Doctors, Drugs, Health Insurance, HMO's/PPO's, Hospitals, Medical Devices, Nursing...
The Scripps Research Institute CEO and President Michael Marletta intends to step down, according to the organization’s board of trustees.
San Diego-based Agena Bioscience, Inc. said that Peter Dansky has joined the company as its chief executive officer and as a member of the board of directors.
AMN Healthcare Services Inc. has promoted Jeanette Sanchez to chief information officer, the company announced.
The International Trade Commission finds continued patent infringement despite products being redesigned.
The grant supports research based on biotechnology licensed from The Scripps Research Institute.
Arena Pharmaceuticals will be eligible for milestone payments.
Task orders under the contract could be worth up to $130.4 million.
BIOTECH: Co. Aims For More Clout Before Considering VC Route
A local biotech startup and its 22-year-old CEO — with support of local industry veterans — are trying a no-strings-attached funding model to finance their research on a potential cancer vaccine.
Biotech: Acquisition Boosts Clinical Readiness; Tax Rebates Offered by City
Illumina Inc. has had an eventful few days as the San Diego-based life science company acquired Myraqa, a regulatory and quality consulting firm specializing in in vitro diagnostics, while moving a step closer to securing a tax rebate agreement with the city of San Diego.
San Diego-based Illumina Inc. has acquired Myraqa, a regulatory and quality consulting firm specializing in in vitro diagnostics, particularly companion diagnostics, Illumina announced.
The city of San Diego plans to provide Illumina Inc. with tax rebates that should ensure the company keeps 300 middle-class manufacturing jobs in town, Mayor Kevin Faulconer announced.
San Diego-based Acadia Pharmaceuticals Inc. appointed Stephen Davis as executive vice president, chief financial officer and chief business officer, effective immediately, the company announced.
The board of directors of the Council of Community Clinics and its subsidiaries named Henry Tuttle as its new chief executive officer.
San Diego-based Otonomy Inc., a clinical-stage biopharmaceutical company focused on the development and commercialization of therapeutics for diseases and disorders of the inner and middle ear, has publicly filed a registration statement with the U.S. Securities and Exchange Commission for a proposed initial public offering of common stock.